Status:
COMPLETED
Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
Lead Sponsor:
Rafic Hariri University Hospital
Collaborating Sponsors:
Heidelberg University
University Hospital Tuebingen
Conditions:
Neovascularization
Tuberculosis
Eligibility:
All Genders
Brief Summary
One complication of uveitis which is driven by an increase in VEGF is the formation of inflammatory ocular neovascularization (ION). Here, we analyze the therapeutic role of intravitreal bevacizumab i...
Detailed Description
Members of the American Society of Retinal specialists, the American Uveitis Society and the International Uveitis Society were invited to contribute their consecutive cases of ION not responding to s...
Eligibility Criteria
Inclusion
- Inflammatory ocular neovascularization (INO)
Exclusion
- Eyes with age-related macular degeneration
- Diabetes mellitus
- Prior cystoid macular edema
- Uncontrolled systemic hypertension
- Cardiovascular disease
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00645697
Start Date
January 1 2007
End Date
March 1 2008
Last Update
March 28 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut
Beirut, Lebanon, 1136044